| Browse All

Kenvue Inc. (KVUE)

Consumer Defensive | Household & Personal Products | Summit, United States | NYSE
17.61 USD +0.15 (0.859%) ⇧ (April 17, 2026, 4 p.m. EDT)
After hours: 17.61

Short-term: ★★☆☆☆ | Long-term: ★★★☆☆ | Dividends: ★★★★☆
Hot Take | April 11, 2026, 3:45 p.m. EDT

KVUE is a defensive stock with a strong dividend yield, making it attractive for income-focused investors. However, the recent price action shows a lack of clear momentum, with the stock trading near its 52-week low. The stock has been in a consolidation phase, which could present a buying opportunity for short-term traders looking to capitalize on potential rebounds. Long-term investors may consider the current dip as an entry point, given the solid fundamentals and the potential for recovery. The dividend yield is a positive factor, but the payout ratio slightly exceeds 1, indicating that the company is not generating enough earnings to sustain the dividend in the long term. Overall, the stock has potential for both short-term and long-term gains, but investors should monitor the market conditions and company performance closely.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
MSTL ✓0.031181
AutoETS0.032161
AutoTheta0.032193
AutoARIMA0.032217

Forecast horizon: 45 days | Selected: MSTL

Forecast Reliability
Score 80%
H-stat 0.04
Ljung-Box p 0.000
Jarque-Bera p 0.198
Excess Kurtosis -0.79
Attribute Value
Sector Consumer Defensive
Ex Dividend Date 2026-02-10
Last Dividend Date 2026-02-10
Debt to Equity Ratio 80.576
Revenue per Share 7.889
Market Cap 33,809,727,488
Trailing P/E 23.17
Forward P/E 14.61
Beta 0.57
Profit Margins 9.72%
Website https://www.kenvue.com

As of April 11, 2026, 3:45 p.m. EDT: Options activity indicates mixed sentiment. The IV (Implied Volatility) is generally moderate, with higher levels observed in some expirations, suggesting uncertainty or anticipation of price movements. The positioning of both calls and puts shows a balance between bullish and bearish expectations. There is notable activity around the ATM (at-the-money) strikes, which may indicate a focus on the current price level. However, the presence of significant OI (Open Interest) in out-of-the-money strikes suggests potential for price swings in either direction. The overall options activity appears to be cautious, with a slight lean towards short-term volatility.


Dividend Data

Yield Summary
Last Yield 1yr Yield 3yr Avg 5yr Avg
1.12% 4.28%
Dividend History
Date Dividend Yield %
2026-02-11 0.208 1.121899
2025-11-12 0.208 1.262080
2025-08-13 0.208 0.981294
2025-05-14 0.205 0.913705
2025-02-12 0.205 1.020192
2024-11-13 0.205 0.933230
2024-08-14 0.205 1.028507
2024-05-07 0.200 1.068655
2024-02-13 0.200 1.126541
2023-11-07 0.200 1.117836
2023-08-25 0.200 0.963797
Additional Data
dividendRate 0.83
dividendYield 4.71
exDividendDate 2026-02-11
trailingAnnualDividendRate 0.825
trailingAnnualDividendYield 0.04725086
lastDividendValue 0.208
lastDividendDate 2026-02-11
dividendDate 2026-02-25

Info Dump

Attribute Value
52 Week Change -0.20925009
Address1 1 Kenvue Way
All Time High 27.795
All Time Low 14.02
Ask 17.59
Ask Size 31,300
Audit Risk 4
Average Analyst Rating 2.8 - Hold
Average Daily Volume10 Day 18,354,210
Average Daily Volume3 Month 36,626,445
Average Volume 36,626,445
Average Volume10Days 18,354,210
Beta 0.57
Bid 17.58
Bid Size 19,900
Board Risk 4
Book Value 5.618
City Summit
Compensation As Of Epoch Date 1,767,139,200
Compensation Risk 5
Country United States
Crypto Tradeable 0
Currency USD
Current Price 17.61
Current Ratio 0.958
Custom Price Alert Confidence HIGH
Date Short Interest 1,774,915,200
Day High 17.795
Day Low 17.5
Debt To Equity 80.576
Display Name Kenvue
Dividend Date 1,771,977,600
Dividend Rate 0.83
Dividend Yield 4.71
Earnings Call Timestamp End 1,762,435,800
Earnings Call Timestamp Start 1,762,435,800
Earnings Growth 0.112
Earnings Quarterly Growth 0.126
Earnings Timestamp 1,771,362,000
Earnings Timestamp End 1,778,157,000
Earnings Timestamp Start 1,778,157,000
Ebitda 3,243,000,064
Ebitda Margins 0.21443
Enterprise To Ebitda 12.755
Enterprise To Revenue 2.735
Enterprise Value 41,365,651,456
Eps Current Year 1.13294
Eps Forward 1.20556
Eps Trailing Twelve Months 0.76
Esg Populated 0
Ex Dividend Date 1,770,768,000
Exchange NYQ
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 17.9282
Fifty Day Average Change -0.31819916
Fifty Day Average Change Percent -0.017748527
Fifty Two Week Change Percent -20.925009
Fifty Two Week High 25.17
Fifty Two Week High Change -7.5599995
Fifty Two Week High Change Percent -0.30035755
Fifty Two Week Low 14.02
Fifty Two Week Low Change 3.5900002
Fifty Two Week Low Change Percent 0.25606278
Fifty Two Week Range 14.02 - 25.17
Financial Currency USD
First Trade Date Milliseconds 1,683,207,000,000
Float Shares 1,914,048,665
Forward Eps 1.20556
Forward P E 14.60732
Free Cashflow 1,807,874,944
Full Exchange Name NYSE
Full Time Employees 21,780
Gmt Off Set Milliseconds -14,400,000
Governance Epoch Date 1,775,001,600
Gross Margins 0.58370996
Gross Profits 8,828,000,256
Has Pre Post Market Data 1
Held Percent Insiders 0.00067000004
Held Percent Institutions 0.95908
Implied Shares Outstanding 1,919,916,307
Industry Household & Personal Products
Industry Disp Household & Personal Products
Industry Key household-personal-products
Is Earnings Date Estimate 1
Language en-US
Last Dividend Date 1,770,768,000
Last Dividend Value 0.208
Last Fiscal Year End 1,766,880,000
Long Business Summary Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.
Long Name Kenvue Inc.
Market us_market
Market Cap 33,809,727,488
Market State CLOSED
Max Age 86,400
Message Board Id finmb_1820759186
Most Recent Quarter 1,766,880,000
Net Income To Common 1,470,000,000
Next Fiscal Year End 1,798,416,000
Non Diluted Market Cap 33,809,726,166
Number Of Analyst Opinions 12
Open 17.5
Operating Cashflow 2,196,999,936
Operating Margins 0.17830999
Overall Risk 5
Payout Ratio 1.0855
Peg Ratio 1.49
Phone 908 874 1200
Post Market Change 0.0
Post Market Change Percent 0.0
Post Market Price 17.61
Post Market Time 1,776,469,763
Previous Close 17.46
Price Eps Current Year 15.54363
Price Hint 2
Price To Book 3.1345675
Price To Sales Trailing12 Months 2.2355018
Profit Margins 0.097200006
Quick Ratio 0.579
Quote Source Name Delayed Quote
Quote Type EQUITY
Recommendation Key hold
Recommendation Mean 2.76923
Region US
Regular Market Change 0.150002
Regular Market Change Percent 0.859115
Regular Market Day High 17.795
Regular Market Day Low 17.5
Regular Market Day Range 17.5 - 17.795
Regular Market Open 17.5
Regular Market Previous Close 17.46
Regular Market Price 17.61
Regular Market Time 1,776,456,002
Regular Market Volume 16,455,203
Return On Assets 0.06609
Return On Equity 0.14388
Revenue Growth 0.032
Revenue Per Share 7.889
Sand P52 Week Change 0.38150132
Sector Consumer Defensive
Sector Disp Consumer Defensive
Sector Key consumer-defensive
Share Holder Rights Risk 7
Shares Outstanding 1,919,916,307
Shares Percent Shares Out 0.0321
Shares Short 61,696,869
Shares Short Previous Month Date 1,772,150,400
Shares Short Prior Month 66,801,459
Short Name Kenvue Inc.
Short Percent Of Float 0.0373
Short Ratio 2.55
Source Interval 15
State NJ
Symbol KVUE
Target High Price 23.0
Target Low Price 18.0
Target Mean Price 19.58333
Target Median Price 19.0
Total Cash 1,062,000,000
Total Cash Per Share 0.554
Total Debt 8,673,999,872
Total Revenue 15,123,999,744
Tradeable 0
Trailing Annual Dividend Rate 0.825
Trailing Annual Dividend Yield 0.04725086
Trailing Eps 0.76
Trailing P E 23.171053
Trailing Peg Ratio 1.5042
Triggerable 1
Two Hundred Day Average 18.12915
Two Hundred Day Average Change -0.5191498
Two Hundred Day Average Change Percent -0.02863619
Type Disp Equity
Volume 16,455,203
Website https://www.kenvue.com
Zip 7,901